| The blood-brain barrier is a physiological boundary layer that works highly selectively and thus protects the brain: On the one hand, pathogens or toxins are effectively prevented from penetrating the brain, on the other hand, however, necessary messengers and nutrients can pass through them unhindered. This selectivity makes it difficult for physicians to examine or treat the brain because drugs or contrast agents for imaging procedures cannot overcome the barrier. | |
| Scientists led by Dr. Jana Hedrich, Prof. Dr. Heiko Luhmann and Prof. Dr. Tanja Weil, in cooperation with the University of Ulm and the University Medical Center of the Johannes Gutenberg University in Mainz have now investigated the suitability of a system based on nanodiamonds as diagnostic and therapeutic method. |
| Nano-diamonds with a size in the range of a millionth of a meter have the advantage of high biocompatibility: they are not degradable for the body, should be well tolerated and are therefore potentially suitable for both diagnostic and therapeutic purposes. | |
| For their research, the scientists have modified the diamonds in two ways: A coating with a biopolymer based on the most abundant protein in human blood, “serum albumin”, enables the diamonds to be absorbed into the brain and later to be combined with drugs. | |
| “Diamonds are chemically non-reactive, which means that it is difficult to bind drug molecules,” says Jana Hedrich and Tanja Weil. “The albumin coating enables us to create a stable coating and bind almost any medication to it.” | |
| As a further modification, a defect was specifically introduced into the diamond by replacing an atom in the diamond, which consisting of carbon, with a nitrogen atom. Furthermore, there is an empty space in the crystal directly next to this nitrogen atom. | |
| “A diamond is normally very clear and, ideally, flawless – light can therefore easily pass through it,” explains Hedrich…. |
Image Credit: University Medical Center of the Johannes Gutenberg University in Main
News This Week
Nanoparticles could help us get closer to a treatment for COVID-19
There is no vaccine or specific treatment for COVID-19, the disease caused by the severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2. Since the outbreak began in late 2019, researchers have been racing to [...]
Corona Virus (COVID 19) Interview with Michael Osterholm an expert in infectious disease epidemiology.
Michael Osterholm is an internationally recognized expert in infectious disease epidemiology. He is Regents Professor, McKnight Presidential Endowed Chair in Public Health, the director of the Center for Infectious Disease Research and Policy [...]
Experts envision two scenarios if the new coronavirus isn’t contained
With the new coronavirus spreading from person to person (possibly including from people without symptoms), reaching four continents, and traveling faster than SARS, driving it out of existence is looking increasingly unlikely. It’s still [...]
Neural cells speed up function in 3D bioprinted skeletal muscle constructs
Wake Forest Institute for Regenerative Medicine (WFIRM) scientists have improved upon the 3D bioprinting technique they developed to engineer skeletal muscle as a potential therapy for replacing diseased or damaged muscle tissue, moving another [...]
Scientists Use a “Synaptor” to Link a Rat Neuron and a Silicon Neuron
An international team of scientists from the University of Southampton, the University of Padova, and the University of Zurich has connected a silicon neuron to a neuron from the rat hippocampus with an artificial [...]
The Ins & Outs of Gene Therapy Drug Development: an interview with NMIN’s Scientific Director
In an insightful 42-minute interview, NMIN’s Scientific Director Dr. Pieter Cullis, a pioneer in liposomal gene and drug delivery, discusses his scientific career with a focus on his contributions to the evolution of [...]
Powerful antibiotic discovered using machine learning for first time
A powerful antibiotic that kills some of the most dangerous drug-resistant bacteria in the world has been discovered using artificial intelligence. The drug works in a different way to existing antibacterials and is the [...]
“Bigger than DNA” — how AI is transforming the pharma industry
Artificial intelligence hit a big milestone in January — the first drug designed entirely using artificial intelligence entered human clinical trials. The compound, created by Oxford-based biotech company Exscientia, is aimed at treating obsessive-compulsive [...]
Achilles’ heel of ALL viruses? Scientists discover holy grail which could lead to UNIVERSAL vaccine
Researchers at the Massachusetts General Hospital (MGH) in the US have uncovered the ‘Achilles’ heel’ of most viruses which plague mankind, and could soon develop a universal vaccine. Vaccine research, development and testing takes [...]
Small world: atom-scale materials are the next tech frontier
Every age in the history of human civilisation has a signature material, from the Stone Age, to the Bronze and Iron Ages. We might even call today’s information-driven society the Silicon Age. Since the [...]
Human textiles to repair blood vessels
What if we could replace a patient's damaged blood vessels with brand new ones produced in a laboratory? This is the challenge set by Inserm researcher Nicolas L'Heureux, who is working on the human [...]
CRISPR cancer trial finds that gene-edited immune cells are safe
CRISPR gene-edited immune cells have been injected into three people with advanced cancer without any serious side effects, the first trial of its kind in the US. It is also the first CRISPR cancer [...]
Updated – Worldwide Press for “Human Brain/Cloud Interface”
“We’ll have nanobots that… connect our neocortex to a synthetic neocortex in the cloud. Our thinking will be a…. biological and non-biological hybrid.” Ray Kurzweil, TED 2014 UPDATE - February 9 2020 Since [...]
NanoApps Athletics Inc. Established
Frank Boehm (NanoApps Medical Inc. founder) and Amanda Scott (NA CEO) join NanoApps Athletics Inc. NanoApps Athletics Inc proposes a unique synergistic biochemical/nanomedical strategy for the expedited repair and healing of Achilles tendon micro [...]
Jamilee Baroud Podcast – Frank Boehm (NA Founder) Interview
In her inaugural podcast, Jamilee interviews Frank Boehm of NanoApps Medical Inc and NanoApps Athletics Inc. From Jamilee's podcast: Welcome to the first episode of "In a Click". On todays show I chat with [...]
A megalibrary of nanoparticles
Using straightforward chemistry and a mix-and-match, modular strategy, researchers have developed a simple approach that could produce over 65,000 different types of complex nanoparticles, each containing up to six different materials and eight segments, [...]
